Intelligent Investors Den!
We are conducting system maintenance, which may temporarily affect some services and our ability to answer phone calls. For urgent queries, please contact us via email using the addresses on our contact page. We appreciate your patience and are working to restore full services promptly. Thank you for your cooperation!
Sign up Now and Gain Access to Exciting Opportunities from Investor and Resource Space!
By submitting your details and clicking on the SIGN UP button you agree to Kalkine’s Free Trial-Terms of Use and consent to receive marketing offers including to be contacted by email or phone, as set out in our Privacy Policy Any calls will be made by Kalkine Pty Ltd or Kalkine Solutions Private Limited on our behalf. You also agree that Kalkine/KSPL can give you its Financial Services Guide by electronic means (including by website link or email). Before accessing our services, please read the Financial Services Guide available here.
By creating account you will get access to hot stocks & personalised emails
Any calls will be made by Kalkine Pty Ltd or Kalkine Solutions Private Limited on our behalf.
Last update at 2024-09-19T06:10:00Z
Visage Launches Visage Ease VP™ for Apple Vision Pro
Pro Medicus Limited's (ASX:PME) Stock Is Going Strong: Is the Market Following Fundamentals?
Visage Soars with CloudPACS at RSNA 2023
Pro Medicus (ASX:PME) jumps 7.4% this week, though earnings growth is still tracking behind five-year shareholder returns
Pro Medicus (ASX:PME) Could Become A Multi-Bagger
53% of Pro Medicus Limited (ASX:PME) is owned by insiders, and they've been buying recently
Pro Medicus Full Year 2023 Earnings: Beats Expectations
Despite recent sales, Pro Medicus Limited (ASX:PME) insiders still hold the largest share with a 51% interest
Pro Medicus And 2 Other High Growth Tech Stocks In Australia
Pro Medicus Limited's (ASX:PME) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
Sector: Healthcare Industry: Health Information Services
Pro Medicus Limited engages in the development and supply of healthcare imaging software and services to hospitals, diagnostic imaging groups, and other related health entities in Australia, North America, and Europe. The company offers Visage radiology information systems (RIS), a proprietary medical software for practice management, training, installation, professional services, and after-sale support and service products; and Promedicus.net, an e-health platform. It also provides healthcare imaging software that provides radiologists and clinicians with visualization capability for viewing 2-D, 3-D, and 4-D medical images, as well as picture archive and communication system (PACS)/digital imaging software; and integration products. In addition, the company offers Visage Ease Pro, a mobile application that provides users the ability to interpret various diagnostic imaging studies stored on a Visage 7 server. The company provides its products under the Visage RIS, Visage RIS/PACS, Visage 7, Visage Ease Pro, and Visage Ease names. Pro Medicus Limited was incorporated in 1983 and is headquartered in Richmond, Australia.
450 Swan Street, Richmond, VIC, Australia, 3121
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to this. Read our Privacy Policy andTerms and Conditions Allow cookies Decline